← Back to Search

Nerve Protector

Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections

N/A
Waitlist Available
Research Sponsored by University of Mississippi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
-Any neck dissection (cervical lymphadenectomy) that involves resection of level 2 cervical lymph nodes for malignancy and does not fall into the categories listed under the
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months.

Summary

The purpose of this study is to determine whether Axoguard nerve protectors have a role in preventing shoulder disability and pain following spinal accessory nerve sparing neck dissections.

Eligible Conditions
  • Shoulder Dropped
  • Cervical Lymphadenopathy

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Shoulder function
Secondary study objectives
Postoperative pain following neck dissection: rate shoulder pain from 1-10

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionalExperimental Treatment1 Intervention
Patients who provide consent for implant placement and do receive the implant.
Group II: ControlPlacebo Group1 Intervention
Patients who provide consent for implant placement but do not receive the implant.

Find a Location

Who is running the clinical trial?

University of Mississippi Medical CenterLead Sponsor
180 Previous Clinical Trials
196,791 Total Patients Enrolled
~15 spots leftby Dec 2025